Crinetics Pharmaceuticals Inc buy Citigroup Inc.
Start price
14.11.24
/
50%
€57.00
Target price
14.11.25
€70.14
Performance (%)
-36.14%
End price
15.11.25
€36.40
Summary
This prediction ended on 15.11.25 with a price of €36.40. Massive losses of -36.14% were the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 6.519% | 6.519% | 32.520% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Citigroup Inc. from $70.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten